Dietary conflicts with standard clinical procedures for colonoscopy in Phenylketonuria: a case report

Colonoscopy is a diagnostic technique used for gastrointestinal tract pathologies that presents additional challenges when used in individuals with phenylketonuria (PKU). The dietary requirements for colonoscopy preparation conflict with a phenylalanine (Phe) restricted diet essential in classical PKU, and aspartame containing laxatives must also be avoided. This case study highlights the complexities of applying conventional colonoscopy protocols to patients with PKU and emphasis the importance of personalized preparation strategies that consider strict dietary requirements. A 24-year-old White British woman with classical PKU, with a Phe tolerance of 250 mg/day (5 g/day natural protein) and a consistent maintenance of blood Phe < 360 µmol/L, required an urgent colonoscopy/gastroscopy for investigation of bowel cancer. In the 3 days preceding the procedure, for the first 48 h she followed a low fibre/residue diet (avoiding fruit/vegetables), followed by 24 h of clear fluids only, omitting the Phe-free amino acid supplements. On the evening before the procedure, the first dose of a bowel preparation solution (Plenvu ® , containing Macrogol 3350 but aspartame-free) was taken. Immediately, she was lightheaded, had a headache with extreme fatigue. Three hours later, she took the second dose of Plenvu ® , containing aspartame (0.88 g/493 mg Phe). Her headache became intense, she felt exhausted and was unaware of her surroundings. It was unclear if the symptoms were caused by side effects associated with the bowel preparation solution or probable high Phe levels following 3 days of a very low energy diet with cessation of protein substitute, together with a high Phe intake associated with the aspartame load. Awareness of potential dietary conflicts with standard procedures, together with effective communication within and between healthcare teams, is essential to ensure patient-centered care. Developing practical guidelines and specific warnings could significantly support both patients and healthcare providers.

Authors

Institutions

Publication Details

Journal
Journal of Medical Case Reports
Published
2026-06-13
DOI
https://doi.org/10.1186/s13256-026-06215-4
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dietary conflicts with standard clinical procedures for colonoscopy in Phenylketonuria: a case report

Anne Grimsley, Suzanne Ford, Martina Tosi, Anita MacDonald et al.
Journal of Medical Case Reports
Metabolism and Genetic Disorders
article

Dietary conflicts with standard clinical procedures for colonoscopy in Phenylketonuria: a case report

Anne Grimsley, Suzanne Ford, Martina Tosi, Anita MacDonald, Alex Pinto, Anne Daly, Elvira Verduci, Catherine Ashmore, Melanie Hill, Sharon Evans
article en

Abstract

Colonoscopy is a diagnostic technique used for gastrointestinal tract pathologies that presents additional challenges when used in individuals with phenylketonuria (PKU). The dietary requirements for colonoscopy preparation conflict with a phenylalanine (Phe) restricted diet essential in classical PKU, and aspartame containing laxatives must also be avoided. This case study highlights the complexities of applying conventional colonoscopy protocols to patients with PKU and emphasis the importance of personalized preparation strategies that consider strict dietary requirements. A 24-year-old White British woman with classical PKU, with a Phe tolerance of 250 mg/day (5 g/day natural protein) and a consistent maintenance of blood Phe < 360 µmol/L, required an urgent colonoscopy/gastroscopy for investigation of bowel cancer. In the 3 days preceding the procedure, for the first 48 h she followed a low fibre/residue diet (avoiding fruit/vegetables), followed by 24 h of clear fluids only, omitting the Phe-free amino acid supplements. On the evening before the procedure, the first dose of a bowel preparation solution (Plenvu ® , containing Macrogol 3350 but aspartame-free) was taken. Immediately, she was lightheaded, had a headache with extreme fatigue. Three hours later, she took the second dose of Plenvu ® , containing aspartame (0.88 g/493 mg Phe). Her headache became intense, she felt exhausted and was unaware of her surroundings. It was unclear if the symptoms were caused by side effects associated with the bowel preparation solution or probable high Phe levels following 3 days of a very low energy diet with cessation of protein substitute, together with a high Phe intake associated with the aspartame load. Awareness of potential dietary conflicts with standard procedures, together with effective communication within and between healthcare teams, is essential to ensure patient-centered care. Developing practical guidelines and specific warnings could significantly support both patients and healthcare providers.

Journal of Medical Case Reports
Belfast Health and Social Care Trust (GB), North Bristol NHS Trust (GB), University of Milan (IT), Chester Zoo (GB), Northern General Hospital (GB), Birmingham Women's Hospital (GB), Ospedale dei Bambini Vittore Buzzi (IT)
Good health and well-being
Openalex Percentile: Top 7%
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.